Incorporated in 2015 and headquartered at TICEL BioPark, Chennai, V S Clinical Research and Hospital Pvt. Ltd. (VSCRH) is an ISO 9001:2015 certified integrated Contract and Clinical Research Organization, which supports R&D programs from lead generation to clinical supplies.
V S Bio Analyticals (VSBA), a unit of VSCRH offers research support to clients. Our multi-disciplinary skills in integrated drug discovery and development include capabilities in microbiology, molecular diagnostics, pre-clinical studies, Cell line platforms, in vivo pharmacology, toxicology and analytical development along with Clinical development services. VSBA provides services from product analysis, sample testing and analytical services to clinical trials for domestic as well as international markets to start-ups, pharmaceutical, biotechnology, agrochemical, chemical, nutrition, animal health companies, Medical, Clinical, Food, Herbal Product and Cosmetics industries.
At VSBA, we believe we have a historic opportunity of building a world class company. Here, we take pride in our atmosphere of collaboration, energy and professionalism. Our merits lie on being a flat, open and communicative organization; our ethos that encourages, promotes and rewards empowerment; initiative; flawless execution and leadership.
VSBA is positioned to provide the most value to our clients. We have an impressive infrastructure tailored to maximizing quality, efficiency, and support, without sacrificing responsiveness and flexibility. With a business model centered on flexibility, VSBA is your research partner of choice.
The training division at VSCRH, also excels in providing trained manpower to the Industry in India by bridging the Gap between Academia and Industry.
The R&D team is working towards the development of invitro, invivo and insilico models for preclinical assay system and early disease diagnosis. It also aims to further innovation driven research in Indian Medical Systems.
VSCRH envisions being a catalyst for new and generic drug development. We aim to become the most desired partner to the Pharmaceutical fraternity globally to deliver safe, quality and best solutions with no compromise on ethical practices, national and international regulatory guidelines in GCP in accordance with ICH.